Sign in
Taking people in United StatesNo phase

Studies how dilated cardiomyopathy and genes affect heart disease in different ethnic groups

Follows adults with dilated cardiomyopathy, a weakened heart condition, across different ethnic groups.

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
UIC Multi-Ethnic DCM Registry
Status
Recruiting
People taking part
1,500 people, planned
Started
11 Jul 2024
Expected to end
31 Dec 2038
Type of study
Observational, 2 groups
Record updated
28 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for adults with dilated cardiomyopathy, a heart condition where the heart cannot pump blood well. They must be admitted to or seen at a UIH site.

Age
18 years or older
Sex
Women and men can join.

Main reasons for not taking part

  • Adults who cannot give consent
  • Women who are pregnant at the baseline visit
  • Prisoners
  • People who are not yet adults (infants, children, teenagers)

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Must be at least 18 years of age and be admitted to or seen at a UIH site
  • Subjects must be willing and able to give written, informed consent

Who cannot take part

  • Adults who are unable to provide consent
  • Women who are pregnant at the baseline visit,
  • Prisoners
  • Individuals who are not yet adults (infants, children, teenagers)

Where in United States

  • University of Illinois Hospital & Health SciencesChicago, United StatesContact: Yining Chen, M.S.Taking people

About the trial

What the trial wants to find out

Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequently and appears to causes greater harm than Whites. However, almost all research related to DCM has been performed in Whites, where up to half of cases run in the family. Several genes have been identified that cause the disease, but we are unsure if these same genes are also responsible for DCM in African Americans or Hispanic/Latino patients. The impact of various medical, social, and financial stressors on the severity of the disease in ethnic minorities also remains unclear. The investigators believe that certain genes are more common in different racial and ethnic groups and the greater medical, social, and financial burden faced by minorities in the US leads to more harm from DCM in these groups. The overall goal of the project is to test whether ethnic minority patients carrying genes that cause DCM experience more adverse effects in part because of various medical, social, and financial burdens. The investigators will first establish the UIC Multi-ethnic DCM Biorepository to look for how often certain genes are found across different race-ethnicity and then ask the question if these genes impact the severity of DCM. Finally, the investigators will study how a person's environment can alter the course of their disease. Through this, the investigators hope and strive to ensure equal and adequate heart care for individuals regardless of their race-ethnicity.

The 2 groups in the trial

  • Dilated Cardiomyopathy
  • Control

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
University of Illinois Chicago (UIC) Multi-Ethnic Dilated Cardiomyopathy (DCM) Registry
Plain-language title
Studies how dilated cardiomyopathy and genes affect heart disease in different ethnic groupsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 August 2025